The invention provides a combination comprising a compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable derivatives or prodrugs thereof and a polymyxin selected from polymyxin E and polymyxin B or a pharmaceutically acceptable derivative thereof. This combination is particularly useful for the treatment of microbial infections.
